Practice patterns in patients at risk for glucocorticoid-induced osteoporosis (Q40391522)

20 September 2017

Practice patterns in patients at risk for glucocorticoid-induced osteoporosis (English)

1 reference

20 September 2017

0 references

Adrianne C Feldstein

1

1 reference

20 September 2017

Patricia J Elmer

series ordinal

2

1 reference

20 September 2017

Gregory A Nichols

series ordinal

3

1 reference

20 September 2017

Michael Herson

series ordinal

4

1 reference

20 September 2017

language of work or name

English

0 references

publication date

3 September 2005

1 reference

Osteoporosis International

20 September 2017

1 reference

20 September 2017

16

1 reference

20 September 2017

2168-2174

1 reference

20 September 2017

12

1 reference

https://scigraph.springernature.com/pub.10.1007/s00198-005-2016-z

20 September 2017

0 references

cites work

Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00198-005-2016-Z

Computer-based guideline implementation systems: a systematic review of functionality and effectiveness

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00198-005-2016-Z

Randomized trial of effect of cyclical etidronate in the prevention of corticosteroid-induced bone loss. Ciblos Study Group

21 January 2018

1 reference

12 December 2020

Incidental vertebral fractures discovered with chest radiography in the emergency department: prevalence, recognition, and osteoporosis management in a cohort of elderly patients

1 reference

12 December 2020

Prevalence of long term steroid treatment and the frequency of decision making to prevent steroid induced osteoporosis in daily clinical practice

1 reference

12 December 2020

Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group

1 reference

12 December 2020

Central Challenges Facing the National Clinical Research Enterprise

1 reference

12 December 2020

Risedronate therapy prevents corticosteroid-induced bone loss: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study

1 reference

12 December 2020

Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice

1 reference

12 December 2020

Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. American College of Rheumatology Task Force on Osteoporosis Guidelines

1 reference

12 December 2020

Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial. European Corticosteroid-Induced Osteoporosis Treatment Study

1 reference

12 December 2020

Clinical judgment and clinical practice guidelines

1 reference

12 December 2020

Older women with fractures: patients falling through the cracks of guideline-recommended osteoporosis screening and treatment.

1 reference

12 December 2020

Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial

1 reference

12 December 2020

The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis

1 reference

12 December 2020

Corticosteroid osteoporosis: practical implications of recent trials

1 reference

12 December 2020

Bone mineral density measurement and treatment for osteoporosis in older individuals with fractures: a gap in evidence-based practice guideline implementation

1 reference

12 December 2020

Variations in glucocorticoid induced osteoporosis prevention in a managed care cohort

1 reference

12 December 2020

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

12 December 2020

Pathogenesis and treatment of glucocorticoid-induced osteoporosis

1 reference

12 December 2020

Multifaceted educational program increases prescribing of preventive medication for corticosteroid induced osteoporosis.

1 reference

12 December 2020

Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis

1 reference

12 December 2020

Prevention of glucocorticoid-induced osteoporosis: experience in a managed care setting

1 reference

12 December 2020

Barriers to osteoporosis identification and treatment among primary care physicians and orthopedic surgeons

1 reference

12 December 2020

Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy

1 reference

12 December 2020

A UK Consensus Group on management of glucocorticoid-induced osteoporosis: an update.

1 reference

12 December 2020

Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis

1 reference

12 December 2020

10.1007/S00198-005-2016-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

20 September 2017

0 references

1 reference